(0.16%) 5 139.50 points
(0.10%) 38 481 points
(0.23%) 17 887 points
(-0.25%) $83.64
(0.99%) $1.942
(0.27%) $2 353.60
(0.69%) $27.73
(1.77%) $938.45
(-0.18%) $0.933
(-0.33%) $10.99
(-0.28%) $0.798
(1.25%) $93.02
-0.96% SEK 0.514
Live Chart Being Loaded With Signals
AegirBio AB (publ), a diagnostic company, develops and commercializes tests to follow the dosage of biological drugs. The company focuses on therapeutic drug monitoring of biologic therapies in the multiple sclerosis, cancer, and autoimmune diseases...
Stats | |
---|---|
Volumen de hoy | 89 692.00 |
Volumen promedio | 137 957 |
Capitalización de mercado | 15.87M |
EPS | SEK0 ( 2024-04-26 ) |
Last Dividend | SEK0 ( N/A ) |
Next Dividend | SEK0 ( N/A ) |
P/E | -0.0300 |
ATR14 | SEK0.0110 (2.14%) |
Volumen Correlación
AegirBio AB (publ) Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
AegirBio AB (publ) Correlación - Moneda/Commodity
AegirBio AB (publ) Finanzas
Annual | 2023 |
Ingresos: | SEK92 000.00 |
Beneficio Bruto: | SEK44 000.00 (47.83 %) |
EPS: | SEK-2.38 |
FY | 2023 |
Ingresos: | SEK92 000.00 |
Beneficio Bruto: | SEK44 000.00 (47.83 %) |
EPS: | SEK-2.38 |
FY | 2022 |
Ingresos: | SEK1.71M |
Beneficio Bruto: | SEK-23.71M (-1 389.57 %) |
EPS: | SEK-18.90 |
Financial Reports:
No articles found.
AegirBio AB (publ)
AegirBio AB (publ), a diagnostic company, develops and commercializes tests to follow the dosage of biological drugs. The company focuses on therapeutic drug monitoring of biologic therapies in the multiple sclerosis, cancer, and autoimmune diseases. It offers moNATor, a first dose-monitoring laboratory test to test multiple sclerosis for healthcare professionals and patients; and Viraspec, a COVID-19 saliva test kit. The company was incorporated in 2019 and is based in Lund, Sweden.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico